A phase 2 study of talimogene laherparepvec, nivolumab, and trabectedin (TNT) in advanced sarcoma

Category Primary study
JournalJournal of Clinical Oncology
Year 2021
This article has no abstract
Epistemonikos ID: fe9c14ff7f264b1abcb3d711a17a5258c6dc130d
First added on: Feb 13, 2025